
TY  - JOUR
AU  - Wilkinson, J. N.
TI  - Thyroid storm in a polytrauma patient
JO  - Anaesthesia
VL  - 63
IS  - 9
SN  - 0003-2409
UR  - https://doi.org/10.1111/j.1365-2044.2008.05541.x
DO  - doi:10.1111/j.1365-2044.2008.05541.x
SP  - 1001
EP  - 1005
PY  - 2008
AB  - Summary We report the case of a 38?year-old woman who presented initially as the driver in a road traffic accident with a Glasgow Coma Score of 14, agitated, tachycardic, tachypnoeic and hypertensive. The combination of an abdominal CT scan and clinical findings led to the decision to perform an emergency laparotomy. Her persisting symptoms and laboratory results revealed her to be manifesting acute thyroid storm; TSH of <?0.10?IU.l?1, free T4 of 59.8?pmol.l?1 and free T3 of 20.20?pmol.l?1.
ER  - 

TY  - JOUR
AU  - JUSTE, R. N.
AU  - LAWSON, A. D.
AU  - SONI, N.
TI  - Minimising cardiac anaesthetic risk: the tortoise or the hare?
JO  - Anaesthesia
VL  - 51
IS  - 3
SN  - 0003-2409
UR  - https://doi.org/10.1111/j.1365-2044.1996.tb13643.x
DO  - doi:10.1111/j.1365-2044.1996.tb13643.x
SP  - 255
EP  - 262
PY  - 1996
ER  - 

TY  - JOUR
TI  - Wednesday 18 January 2012
JO  - Developmental Medicine & Child Neurology
VL  - 54
IS  - s1
SN  - 0012-1622
UR  - https://doi.org/10.1111/j.1469-8749.2011.04191.x
DO  - doi:10.1111/j.1469-8749.2011.04191.x
SP  - 20
EP  - 54
PY  - 2012
ER  - 

TY  - JOUR
TI  - 2018 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 32
IS  - 6
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.15319
DO  - doi:10.1111/jvim.15319
SP  - 2144
EP  - 2309
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts for the 2019 Scandinavian Society of Anaesthesiology and Intensive Care Medicine Congress in Copenhagen
JO  - Acta Anaesthesiologica Scandinavica
JA  - Acta Anaesthesiol Scand
VL  - 63
IS  - 8
SN  - 0001-5172
UR  - https://doi.org/10.1111/aas.13442
DO  - doi:10.1111/aas.13442
SP  - e1
EP  - e48
PY  - 2019
ER  - 

AU  - Mathews, Karol
C7  - pp. 17-50
TI  - Physiologic and Pharmacologic Applications to Manage Neuropathic Pain
SN  - 9781119036562
UR  - https://doi.org/10.1002/9781119036500.ch3
DO  - doi:10.1002/9781119036500.ch3
SP  - 17-50
KW  - clinical relevance
KW  - diagnostic methods
KW  - nervous system
KW  - neuropathic pain
KW  - pharmacological intervention
KW  - physiology intervention
KW  - primary lesions
KW  - therapeutic modalities
KW  - treatment procedure
PY  - 2019
AB  - Summary The origin of neuropathic pain may be difficult to diagnose unless an obvious predisposing lesion or injury to the nervous system is easily identified, or a genetic predisposition exists. Understanding the physiology and events that occur in the nervous system, originating from poorly managed acute pain, chronic pain or from primary lesions within the nervous system is important, as individual mechanisms causing pain are targets for therapeutic consideration. Some lesions may be amenable to surgical therapy, whereas others will require specific pharmacological intervention. In the human setting, the diagnosis of neuropathic pain may be based solely on history and examination findings as judged by an experienced clinician. The chapter illustrates examples of the more common clinical conditions causing neuropathic neck and back pain in cats and dogs. Prior to, and often during, any surgical procedure, various different analgesics and analgesic modalities can be used to reduce the inciting nociceptive afferent impulse.
ER  - 

TY  - JOUR
TI  - Abstracts-part II (Continue in Part III)
JO  - Proceedings of the International Society for Magnetic Resonance in Medicine
JA  - Proc. Soc. Magn. Reson. Med.
VL  - 1995
IS  - S1
SN  - 9781119036562
UR  - https://doi.org/10.1002/mrmp.22419950104
DO  - doi:10.1002/mrmp.22419950104
SP  - 101
EP  - 150
PY  - 1995
ER  - 

C7  - pp. 1-486
TI  - English to Spanish
SN  - 9781118237977
UR  - https://doi.org/10.1002/9781118797907.ch1
DO  - doi:10.1002/9781118797907.ch1
SP  - 1-486
KW  - Absolute accuracy
KW  - Absorbance
KW  - Absorption paper
KW  - Abundance ratio
KW  - Acclimatisation
KW  - Backdonation
KW  - Backextraction
KW  - Balanced reaction
KW  - Barff process
KW  - Barium acetate
KW  - Carbon
KW  - Cacao butter
KW  - Cacodylic acid
KW  - Cadmium acetate
KW  - Cacodyl chloride
KW  - Dactinomycin
KW  - Dahllite
KW  - Dahmenite
KW  - Dark resistance
KW  - Darmstadtium
KW  - E-book
KW  - E-mail
KW  - Ecgonine
KW  - Eclogite
KW  - Eclampsia
KW  - Fabianol
KW  - Face-centered cubic
KW  - Factor analysis
KW  - Fahrenheit degree
KW  - False positive
KW  - Gabriel reaction
KW  - Gadoleic acid
KW  - Gadolinium bromide
KW  - Galactorrhea
KW  - Galenite
KW  - Haemochrome
KW  - Haemophilia
KW  - Hafnium disulphide
KW  - Halogenating agent
KW  - Hamiltonian mechanics
KW  - Iatrogenic disease
KW  - Iceland moss
KW  - Ichthyocolla
KW  - Icosahedron
KW  - Identity period
KW  - Jacobsen rearrangement
KW  - Janovsky reaction
KW  - Jasmine oil
KW  - Jasmone
KW  - Jeweller's rogue
KW  - Kairomone
KW  - Kappa receptor
KW  - Kava kava
KW  - Keesom relationship
KW  - Kelvin effect
KW  - Lab apparatus
KW  - Lab coat
KW  - Labyrinth
KW  - Labradorite
KW  - Lycopodium
KW  - Macrobiotic diet
KW  - Magnesium bromide
KW  - Maintenance medications
KW  - Magnetisability
KW  - Magnetoencephalograph
KW  - Nalorphine
KW  - Nano-electronics
KW  - Naphthyl alcohol
KW  - Natrolite
KW  - Natural alloy
KW  - Obermayer reagent
KW  - Occlusion
KW  - Ohm's law
KW  - Olfactory cells
KW  - Olfactory stimulation
KW  - Palate
KW  - Palindrome
KW  - Pamoic acid
KW  - Palmitolic acid
KW  - Palmitoyl chloride
KW  - Quadruple resonance
KW  - Qualitative analysis
KW  - Quantitative inheritance
KW  - Quantitative reaction
KW  - Quantum equivalence
KW  - Racemic acid
KW  - Radiation absorber
KW  - Radiation effect
KW  - Radiation hazard
KW  - Radio-carbon
KW  - Radiative capture
KW  - Sabinol
KW  - Saccharase
KW  - Saccharification
KW  - Sacrificial donor
KW  - Safranine
KW  - Tachiol taconite
KW  - Tacrine
KW  - Tactic polymer
KW  - Tactosol
KW  - Ullman reaction
KW  - Ulmin ulcer
KW  - Ultiva
KW  - Ultraviolet radiation
KW  - Vaccination
KW  - Vacuum crystalliser
KW  - Valence transition
KW  - Valeraldehyde
KW  - Valerian oil
KW  - Wacker reaction
KW  - Wagnerite
KW  - Warfarin
KW  - Water sterilisation
KW  - Water still
KW  - X chromosome
KW  - X-ray analysis
KW  - Xenol
KW  - Xenon
KW  - Xenylamine
KW  - Y chromosome yacca gum
KW  - Yttrium nitrate
KW  - Yttrium oxide
KW  - Yttrotantalite
KW  - Zaleplon
KW  - Zaratite
KW  - Zeaxanthin
KW  - Zeeman effect
KW  - Zeise sait
PY  - 1995
AB  - Summary This chapter contains sections titled: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Greek Letters
ER  - 

TY  - JOUR
TI  - Abstracts from the 14th Congress of the International Society for Rotary Blood Pumps
JO  - Artificial Organs
VL  - 30
IS  - 11
SN  - 9781118237977
UR  - https://doi.org/10.1111/j.1525-1594.2006.00320.x
DO  - doi:10.1111/j.1525-1594.2006.00320.x
SP  - A27
EP  - A50
PY  - 2006
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 48
IS  - s2
SN  - 9781118237977
UR  - https://doi.org/10.1111/j.1537-2995.2008.01891.x
DO  - doi:10.1111/j.1537-2995.2008.01891.x
SP  - 1A
EP  - 241A
PY  - 2008
ER  - 

TY  - JOUR
TI  - The abstracts of Eurosurgery 95
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 82
IS  - S1
SN  - 9781118237977
UR  - https://doi.org/10.1002/bjs.1800821302
DO  - doi:10.1002/bjs.1800821302
SP  - 1
EP  - 144
PY  - 1995
ER  - 

TY  - JOUR
AU  - Kim, Hae Won
AU  - Greenburg, A. Gerson
TI  - Artificial Oxygen Carriers as Red Blood Cell Substitutes: A Selected Review and Current Status
JO  - Artificial Organs
VL  - 28
IS  - 9
SN  - 9781118237977
UR  - https://doi.org/10.1111/j.1525-1594.2004.07345.x
DO  - doi:10.1111/j.1525-1594.2004.07345.x
SP  - 813
EP  - 828
KW  - Hemoglobin-based oxygen carrier
KW  - Perfluorocarbon-based oxygen carrier
KW  - Blood substitute
KW  - Hemoglobin
KW  - Perfluorocarbon
PY  - 2004
AB  - Abstract:? Two distinct approaches are being explored in red blood cell substitute (RCS) development: hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon-based oxygen carriers (PFBOCs). HBOCs are based on intra- and/or intermolecularly ?engineered? human or animal hemoglobins (Hbs), optimized for O2 delivery and longer intravascular circulation. Some are currently being evaluated in Phase II/III clinical studies. PFBOCs are aqueous emulsions of perfluorocarbon derivatives that dissolve relatively large amounts of O2. A PFBOC based on a 60% (wt/vol) emulsion of perfluorooctyl bromide has been evaluated in Phase II/III clinical trials. Although current PFBOC products generally require patients to breathe O2 enriched air, they render certain advantages since they are totally synthetic. This article provides a short review of the basic principles, approaches, and current status of RCS development. Results of preclinical and clinical studies including recent Phase II/III clinical studies are discussed.
ER  - 

TY  - JOUR
AU  - HUNT, THOMAS K.
TI  - Foreword
JO  - Annals of the New York Academy of Sciences
VL  - 1066
IS  - 1
SN  - 9781118237977
UR  - https://doi.org/10.1196/annals.1363.037
DO  - doi:10.1196/annals.1363.037
SP  - vii
EP  - viii
PY  - 2006
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 2011 ACVIM Forum Denver, Colorado, June 15â€“18, 2011
JO  - Journal of Veterinary Internal Medicine
VL  - 25
IS  - 3
SN  - 9781118237977
UR  - https://doi.org/10.1111/j.1939-1676.2011.0726.x
DO  - doi:10.1111/j.1939-1676.2011.0726.x
SP  - 632
EP  - 767
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 11
IS  - s2
SN  - 9781118237977
UR  - https://doi.org/10.1111/j.1477-2574.2009.00100.x
DO  - doi:10.1111/j.1477-2574.2009.00100.x
SP  - 1
EP  - 172
PY  - 2009
ER  - 

AU  - O'Beirne, James
AU  - Murphy, Nicholas
AU  - Wendon, Julia
C7  - pp. 661-684
TI  - Fulminant Hepatic Failure: Treatment
SN  - 9781405181938
UR  - https://doi.org/10.1002/9781444314403.ch41
DO  - doi:10.1002/9781444314403.ch41
SP  - 661-684
KW  - Fulminant hepatic failure: Treatment
KW  - fulminant hepatic failure (FHF)
KW  - Intensive care management versus ward management
KW  - orthotopic liver transplantation (OLT)
KW  - Fluid resuscitation and circulatory management
KW  - central venous pressure (CVP)
KW  - pulmonary artery occlusion pressure (PAOP)
KW  - stroke volume variation (SVV)
KW  - pulse pressure variation (PPV)
KW  - cerebral perfusion pressure (CPP)
PY  - 2009
AB  - Summary This chapter contains sections titled: Introduction General supportive management Management of cerebral edema Renal failure Specific therapies Liver transplantation References
ER  - 

TY  - JOUR
AU  - Thomas, Michael C.
AU  - Acquisto, Nicole M.
AU  - Patanwala, Asad E.
AU  - Weant, Kyle A.
AU  - Baker, Stephanie N.
TI  - Key Articles and Guidelines for the Emergency Medicine Pharmacist
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 31
IS  - 12
SN  - 9781405181938
UR  - https://doi.org/10.1592/phco.31.12.1265
DO  - doi:10.1592/phco.31.12.1265
SP  - 1265
EP  - 1265
KW  - drug therapy
KW  - emergency department
KW  - ED
KW  - ER
KW  - key articles
KW  - guidelines
PY  - 2011
AB  - Compilations of articles important to the pharmacist practicing in the emergency department have not been published. Consistent with other specialty areas of practice, a collection of important literature is valuable for both the new and experienced clinician. A diverse breadth of medical problems are represented that were felt to be the most pertinent issues facing the emergency medicine pharmacist; however, it is not intended to be a complete representation of available literature.
ER  - 

TY  - JOUR
TI  - Poster Session PSM01: Neurogenesis and regeneration
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781405181938
UR  - https://doi.org/10.1111/j.1474-1644.2005.03228_12.x
DO  - doi:10.1111/j.1474-1644.2005.03228_12.x
SP  - 20
EP  - 22
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PSM04: Gene expression and signaling I
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781405181938
UR  - https://doi.org/10.1111/j.1474-1644.2005.03228_15.x
DO  - doi:10.1111/j.1474-1644.2005.03228_15.x
SP  - 33
EP  - 35
PY  - 2005
ER  - 

TY  - JOUR
AU  - Notterpek, L.
TI  - Symposium S02: Progress on the pathogenesis of hereditary neurodegenerative disorders
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781405181938
UR  - https://doi.org/10.1111/j.1474-1644.2005.03228_3.x
DO  - doi:10.1111/j.1474-1644.2005.03228_3.x
SP  - 4
EP  - 5
PY  - 2005
ER  - 
